April 29 - Breakingviews columnists discuss the U.S. drug giant’s hankering for AstraZeneca and whether more so-called inversion deals will follow suit.
01:07
01:04
02:08
01:14
01:07
02:03
00:34
00:42
02:03
00:49
01:13
02:17
01:15
01:22
00:56
01:14
01:37
01:17
00:59
00:59
01:04
00:49
00:36
01:32
01:33
01:24
01:18
00:56
01:06
01:13
01:38
02:53
01:59
01:10
00:57
00:56
01:57
00:52
01:17
01:35
00:34
00:42
01:37
01:17
00:59
01:29
00:56
01:00
01:03
00:58
00:39
01:59
01:39
00:58
01:07
00:46
00:22
01:21
01:27
00:53
02:08
01:44
02:15
01:17
05:53
02:08
02:32
01:11
01:14
00:58
01:59
01:15
01:43
01:16
04:26
01:40
01:26
01:28
01:13
01:01
01:39
01:18
02:14
01:00
01:01
01:10
01:42
01:08
01:00
01:31
01:37
01:34
01:27
00:23
01:21
00:52
02:00
01:05
01:44
01:29
01:15
01:18
03:11
01:44
01:34
01:15
01:20
01:20
03:01
00:51
00:50
01:26
01:18
02:49
00:59
02:19
02:19
01:59
00:49
00:38